ScoreWhy is Betta Pharmaceuticals Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 15.17% and Operating profit at 9.21% over the last 5 years
2
With ROE of 5.72%, it has a very expensive valuation with a 2.98 Price to Book Value
- Over the past year, while the stock has generated a return of 23.98%, its profits have fallen by -18.2%
- At the current price, the company has a high dividend yield of 0.7
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Betta Pharmaceuticals Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Betta Pharmaceuticals Co., Ltd.
-24.79%
2.05
47.60%
China Shanghai Composite
3.0%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
15.17%
EBIT Growth (5y)
9.21%
EBIT to Interest (avg)
8.78
Debt to EBITDA (avg)
2.27
Net Debt to Equity (avg)
0.31
Sales to Capital Employed (avg)
0.37
Tax Ratio
25.25%
Dividend Payout Ratio
20.63%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.26%
ROE (avg)
7.69%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
63
Industry P/E
Price to Book Value
3.59
EV to EBIT
42.64
EV to EBITDA
25.53
EV to Capital Employed
3.00
EV to Sales
7.08
PEG Ratio
NA
Dividend Yield
0.25%
ROCE (Latest)
7.05%
ROE (Latest)
5.72%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET SALES(9M)
At CNY 2,867.92 MM has Grown at 25.86%
INVENTORY TURNOVER RATIO(HY)
Highest at 3.2 times
DEBT-EQUITY RATIO
(HY)
Lowest at 30.39 %
-11What is not working for the Company
PRE-TAX PROFIT(Q)
At CNY 54.84 MM has Fallen at -60.76%
NET PROFIT(Q)
At CNY 29.22 MM has Fallen at -70.42%
INTEREST COVERAGE RATIO(Q)
Lowest at 1,052.31
CASH AND EQV(HY)
Lowest at CNY 965.99 MM
OPERATING PROFIT(Q)
Lowest at CNY 194.63 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 20.79 %
Here's what is working for Betta Pharmaceuticals Co., Ltd.
Inventory Turnover Ratio
Highest at 3.2 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
At CNY 2,867.92 MM has Grown at 25.86%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Debt-Equity Ratio
Lowest at 30.39 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Betta Pharmaceuticals Co., Ltd.
Pre-Tax Profit
At CNY 54.84 MM has Fallen at -60.76%
over average net sales of the previous four periods of CNY 139.75 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 29.22 MM has Fallen at -70.42%
over average net sales of the previous four periods of CNY 98.79 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest Coverage Ratio
Lowest at 1,052.31
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit
Lowest at CNY 194.63 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 20.79 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Cash and Eqv
Lowest at CNY 965.99 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Footer loading
